+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Aptevo Therapeutics Inc (APVO) - Financial and Strategic SWOT Analysis Review

Aptevo Therapeutics Inc (APVO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Aptevo Therapeutics Inc (Aptevo) is a clinical-stage biotechnology company that develops and commercializes oncology and hematology therapeutics. Its pipeline products include APVO436 for the treatment of myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML); ALG.APV-527 for potential treatment of a broad spectrum of cancers including mesothelioma, cervical, prostate, renal, breast, non-small-cell-lung, gastric, colorectal and bladder cancers; APVO603 for solid tumors. Aptevo has received Orphan Drug Designation (ODD) for its pipeline product APVO436 from the US FDA for the treatment of acute myelogenous leukemia (AML). The pipeline immuno-oncology candidates are built on its proprietary Adaptir and Adaptir-Flex platform technologies. Aptevo is headquartered in Seattle, Washington, the US.

Aptevo Therapeutics Inc Key Recent Developments

  • May 11, 2023: Aptevo Therapeutics Reports 1Q23 Financial Results and Provides Business Update
  • Nov 10, 2022: Aptevo Therapeutics reports third quarter 2022 financial results and business highlights
  • Aug 12, 2022: Aptevo Therapeutics reports second quarter 2022 financial results and business highlights
  • Mar 24, 2022: Aptevo Therapeutics reports 2021 financial results and provides business update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Aptevo Therapeutics Inc - Key Facts
  • Aptevo Therapeutics Inc - Key Employees
  • Aptevo Therapeutics Inc - Key Employee Biographies
  • Aptevo Therapeutics Inc - Major Products and Services
  • Aptevo Therapeutics Inc - History
  • Aptevo Therapeutics Inc - Company Statement
  • Aptevo Therapeutics Inc - Locations And Subsidiaries
  • Head Office
Section 2 - Company Analysis
  • Company Overview
  • Aptevo Therapeutics Inc - Business Description
  • R&D Overview
  • Aptevo Therapeutics Inc - Corporate Strategy
  • Aptevo Therapeutics Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Aptevo Therapeutics Inc - Strengths
  • Aptevo Therapeutics Inc - Weaknesses
  • Aptevo Therapeutics Inc - Opportunities
  • Aptevo Therapeutics Inc - Threats
  • Aptevo Therapeutics Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Aptevo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Aptevo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Aptevo Therapeutics Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • May 11, 2023: Aptevo Therapeutics Reports 1Q23 Financial Results and Provides Business Update
  • Nov 10, 2022: Aptevo Therapeutics reports third quarter 2022 financial results and business highlights
  • Aug 12, 2022: Aptevo Therapeutics reports second quarter 2022 financial results and business highlights
  • Mar 24, 2022: Aptevo Therapeutics reports 2021 financial results and provides business update
  • Jan 21, 2022: Aptevo Therapeutics' Board Chairman, Fuad El-Hibri, announces retirement
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Aptevo Therapeutics Inc, Key Facts
  • Aptevo Therapeutics Inc, Key Employees
  • Aptevo Therapeutics Inc, Key Employee Biographies
  • Aptevo Therapeutics Inc, Major Products and Services
  • Aptevo Therapeutics Inc, History
  • Aptevo Therapeutics Inc, Key Competitors
  • Aptevo Therapeutics Inc, Ratios based on current share price
  • Aptevo Therapeutics Inc, Annual Ratios
  • Aptevo Therapeutics Inc, Interim Ratios
  • Aptevo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Aptevo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Aptevo Therapeutics Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Aptevo Therapeutics Inc, Performance Chart (2018 - 2022)
  • Aptevo Therapeutics Inc, Ratio Charts
  • Aptevo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Aptevo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

Samples

Loading
LOADING...

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Grifols USA LLC
  • Bristol-Myers Squibb Co
  • Astellas Pharma Inc
  • Harpoon Therapeutics Inc
  • F-star Biotechnology Ltd
  • AbbVie Inc
  • Bayer AG
  • MacroGenics Inc
  • Boehringer Ingelheim International GmbH
  • Biogen Inc
  • Gilead Sciences Inc
  • Bioverativ Inc
  • AnaptysBio Inc
  • Amgen Inc
  • Genmab AS
  • MacroGenics Inc
  • Biogen Inc
  • Bayer AG
  • Bioverativ Inc
  • AnaptysBio Inc
  • Amgen Inc
  • Astellas Pharma Inc